Bone Marrow TransplantationTransplantation, HomologousBone MarrowBone Marrow CellsBlood Transfusion, AutologousGraft vs Host DiseaseTransplantation, AutologousHematopoietic Stem Cell TransplantationBlood TransfusionTransplantation ConditioningWhole-Body IrradiationTransplantation ChimeraLeukemiaBone and BonesOperative Blood SalvageAnemia, AplasticGraft SurvivalHistocompatibility TestingTissue DonorsLiver TransplantationBusulfanBone Marrow PurgingHistocompatibilityTransplantation, IsogeneicHematopoietic Stem CellsRecurrenceBlood Loss, SurgicalTreatment OutcomeCyclophosphamideImmunosuppressive AgentsErythrocyte TransfusionHemodilutionBone Marrow DiseasesHematopoiesisKidney TransplantationMice, Inbred C57BLHematologic NeoplasmsRadiation ChimeraLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLeukemia, Myeloid, AcuteCombined Modality TherapyGraft RejectionRemission InductionBlood CellsTime FactorsPrecursor Cell Lymphoblastic Leukemia-LymphomaTransplantation ImmunologyGraft vs Host ReactionStem Cell TransplantationBone Marrow ExaminationHepatic Veno-Occlusive DiseaseRetrospective StudiesT-LymphocytesImmunosuppressionLymphocyte DepletionLeukemia, MyeloidLeukocyte TransfusionAcute DiseaseBone RemodelingGranulocyte Colony-Stimulating FactorBone Marrow NeoplasmsLymphoma, Non-HodgkinHeart TransplantationHLA AntigensMyelodysplastic SyndromesChimeraSurvival AnalysisGraft vs Tumor EffectPlatelet TransfusionSevere Combined ImmunodeficiencySurvival RateColony-Forming Units AssayHematologic DiseasesFollow-Up StudiesGraft vs Leukemia EffectCyclosporineLeukocyte CountActuarial AnalysisSpleenLung TransplantationNuclear FamilyMice, Inbred BALB CAntineoplastic Combined Chemotherapy ProtocolsProspective StudiesBone DensityCytomegalovirus InfectionsCell DifferentiationLymphocyte TransfusionPancytopeniaFlow CytometryCarmustineCytarabineOrgan TransplantationLife TablesCells, CulturedBlood Cell CountPerioperative CareBlood DonorsMelphalanMultiple Myeloma